Etid klinik pou Emofili B nan Georgia
4 etid pou Emofili B ap chèche patisipan nan sit nan Georgia.
Vil nan Georgia
Tèks ofisyèl etid la (Anglè)
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- Arthur M. Blank Hospital - Children's Healthcare of Atlanta, Atlanta
Ap rekriteFaz 3
138 Months – 206 Months · Gason · Mizajou Sep 16, 2026 · NCT07080905SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
- Children's Healthcare of Atlanta, Atlanta
- Emory University Hospital, Atlanta
Ap rekriteFaz 3
Laj 6 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT04563520ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta, Atlanta
- Emory/Children's Health Care of Atlanta, Atlanta
- Memorial Health University Medical Center, Savannah
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division, Atlanta
- Willett Children's Hospital at Memorial University Medical Center, Savannah
Ap rekriteFaz 4
Laj 12 a 100 · Tout sèks · Mizajou Jan 12, 2026 · NCT04647227Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.